Morepen Laboratories Statistics

Total Valuation

NSE:MOREPENLAB has a market cap or net worth of INR 29.83 billion. The enterprise value is 28.30 billion.

Market Cap	29.83B
Enterprise Value	28.30B

Important Dates

The next estimated earnings date is Monday, May 5, 2025.

Earnings Date	May 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.95%
Shares Change (QoQ)	+1.59%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	307.37M

Valuation Ratios

The trailing PE ratio is 23.67.

PE Ratio	23.67
Forward PE	n/a
PS Ratio	1.67
PB Ratio	2.69
P/TBV Ratio	2.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	22.46
EV / Sales	1.59
EV / EBITDA	15.39
EV / EBIT	16.30
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.03
Debt / EBITDA	0.18
Debt / FCF	n/a
Interest Coverage	38.83

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	11.07%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	8.29M
Profits Per Employee	585,435
Employee Count	2,152
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.02% in the last 52 weeks. The beta is 1.45, so NSE:MOREPENLAB's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	+10.02%
50-Day Moving Average	50.64
200-Day Moving Average	69.10
Relative Strength Index (RSI)	64.80
Average Volume (20 Days)	5,995,330

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:MOREPENLAB had revenue of INR 17.84 billion and earned 1.26 billion in profits. Earnings per share was 2.40.

Revenue	17.84B
Gross Profit	6.56B
Operating Income	1.74B
Pretax Income	1.72B
Net Income	1.26B
EBITDA	1.84B
EBIT	1.74B
Earnings Per Share (EPS)	2.40

Full Income Statement

Balance Sheet

The company has 1.86 billion in cash and 334.95 million in debt, giving a net cash position of 1.53 billion.

Cash & Cash Equivalents	1.86B
Total Debt	334.95M
Net Cash	1.53B
Net Cash Per Share	n/a
Equity (Book Value)	11.10B
Book Value Per Share	20.71
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 36.78%, with operating and profit margins of 9.73% and 7.06%.

Gross Margin	36.78%
Operating Margin	9.73%
Pretax Margin	9.62%
Profit Margin	7.06%
EBITDA Margin	10.31%
EBIT Margin	9.73%
FCF Margin	n/a

Dividends & Yields

NSE:MOREPENLAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.95%
Shareholder Yield	-3.95%
Earnings Yield	4.22%
FCF Yield	n/a

Stock Splits

The last stock split was on November 6, 2000. It was a forward split with a ratio of 5.

Last Split Date	Nov 6, 2000
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a